{"id":"W2794447083","doi":"10.1002/14651858.cd012990.pub2","title":"GLP-1 receptor agonists for Parkinson's disease","year":2020,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Exenatide; Medicine; Dulaglutide; Placebo; Internal medicine; Cochrane Library; Clinical trial; Glucagon-like peptide 1 receptor; Oncology; Type 2 diabetes; Pharmacology; Diabetes mellitus; Agonist; Receptor; Endocrinology; Randomized controlled trial; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009239636,0.001269688,0.007460099,0.01309423,0.0006611343,0.003083273,0.002207906,0.003894899,0.02370262],"category_scores_gemma":[0.03235252,0.0006344809,0.003796192,0.01099899,0.001216642,0.002673892,0.001546441,0.001793538,0.002432142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003650986,"about_ca_system_score_gemma":0.006137484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003191699,"about_ca_topic_score_gemma":0.006750851,"domain_scores_codex":[0.9903173,0.003626762,0.003747567,0.0005007503,0.001637606,0.0001698937],"domain_scores_gemma":[0.9787295,0.01248408,0.006948734,0.0002489199,0.001273356,0.0003154641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004193689,0.00001865464,0.0001741217,0.8991976,0.001041952,0.0001724681,0.0001230608,0.00005991523,0.0001921626,0.0008041213,0.01172096,0.08607554],"study_design_scores_gemma":[0.001279767,0.0002644276,0.001393661,0.8982782,0.006887843,0.0006794741,0.0001436115,0.00005352223,0.0002029127,0.001254335,0.08952902,0.00003315774],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003311368,0.9960497,0.0001102746,0.000546983,0.0003154051,0.0005374312,0.0003807701,0.00001738875,0.001710993],"genre_scores_gemma":[0.006348603,0.9865297,0.001012565,0.002506585,0.000404548,0.001687391,0.0004084637,0.00001797303,0.001084139],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02370262,"threshold_uncertainty_score":0.07929319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1120242106488102,"score_gpt":0.3802424003379355,"score_spread":0.2682181896891253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}